Insights into Company

Procter & Gamble ↗

Package Goods/Cosmetics company

📍 Mumbai, Maharashtra, United States Active NYSE PG CIN L99999MH1967PLC013726 Pharmaceuticals & Healthcare
Search companies

Key Metrics of Procter & Gamble

Revenue$82.0B▲ 2.3% YoYFY 2023
Operating income$18.1B▲ 1.8% YoY
Net profit$14.7B▼ 0.6% YoY
Shareholders' equity$48.8B
Market cap$385BPG · $165.59
Competitors10identified

About Procter & Gamble

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Website
pg.com
Registered office
P & G Plaza, Cardinal Gracias Road Chakala, Andheri East, Mumbai City, Mumbai, In-mh, 400099
Listed
NYSE: PG

Operational Areas of Procter & Gamble

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Entity details

CINL99999MH1967PLC013726
LEI code3358008EZOXHCL1OF384
State codeMH
PIN code400099
Current legal namePROCTER & GAMBLE
Classification—
Listing statusListed
Registration no.013726
Company age—
PAN—
CountryUnited States
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code99999
Description of main activityExtra-territorial organisations and bodies
Description of business activityExtra-territorial organisations and bodies
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing

US market & SEC filings

PG · NYSE  ·  SEC CIK 0000080424

Last price · 23 Oct 2026 $165.59 +5.58%
Market cap$385B
P/E28.1On FY 2023 diluted EPS
Volume22,037,251
SectorConsumer DiscretionaryPackage Goods/Cosmetics
Country · IPOUnited States

PG share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 6 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 36 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Registered office and contact

Registered officeP & G PLAZA, CARDINAL GRACIAS ROAD CHAKALA, ANDHERI EAST, MUMBAI CITY, MUMBAI, IN-MH, 400099
GSTIN—
Email—
Websitehttp://www.pg.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Procter & Gamble

Competitors10identified
Locations1most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Eli Lilly and Company Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare lilly.com — United States
Johnson & Johnson Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare jjmt.com.tw — United States
Merck & Co. Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare merck.com — United States
Amgen Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare amgen.com 1983 United States
Gilead Sciences Part of Gilead Sciences. gilead.com 1992 United States
Abbott Laboratories Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare abbott.com — United States
Pfizer Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pfizer.com — United States
Bristol-Myers Squibb Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare bms.com — United States
Marriott International Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare marriott.com.cn — United States
HCA Healthcare Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare hcahealthcare.com 2011 United States

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Business activities and related parties

pharmaceutical industry, fast-moving consumer goods

Filings

No filings on record yet.